Lawsuit NOTICE: Investors Who Lost More Than $100,000 With Allarity Therapeutics, Inc. (NASDAQ: ALLR) Shares Should Contact the Shareholders Foundation

SAN DIEGO, CA, September 25, 2024 (Newswire.com) - A lawsuit is pending for certain investors in Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares. Investors in NASDAQ: ALLR shares should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554

The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares.

Investors, who purchased a significant amount of shares of Allarity Therapeutics, Inc. (NASDAQ: ALLR) between May 17, 2022 and July 19, 2024, and / or those who purchased any NASDAQ: ALLR shares prior to May 2022 continue to hold any of those shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

On September 13, 2024, an investor in NASDAQ: ALLR shares filed a lawsuit over alleged securities laws violations by Allarity Therapeutics, Inc. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose tha Defendants had overstated the Dovitinib NDA's continued regulatory prospects, that Allarity and three of its former officers had engaged in illegal, illicit, and/or otherwise improper conduct in connection with the Dovitinib NDA and/or the Dovitinib-DRP PMA, that the foregoing misconduct subjected the Company to an increased risk of regulatory and/or governmental scrutiny and enforcement action, as well as significant legal, monetary, and reputational harm, that following Allarity's announcement that it was, in fact, being investigated for wrongdoing in connection with the Dovitinib NDA and/or the Dovitinib-DRP PMA, the Company downplayed the substantial likelihood that an enforcement action would result from such investigation, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Allarity Therapeutics, Inc. (NASDAQ: ALLR) should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact Information

Michael Daniels
Manager
[email protected]
858-779-1554

SOURCE: Shareholders Foundation, Inc.

Source: Shareholders Foundation, Inc.